Longevity Biomarkers: The Complete Reference for Men Who Want to Live Longer, Better
The definitive guide to longevity biomarkers for high performers. Tier 1-3 panels, optimal ranges, mechanisms, and how to get tested.
The definitive guide to longevity biomarkers for high performers. Tier 1-3 panels, optimal ranges, mechanisms, and how to get tested.
You cannot optimize what you do not measure. Here is what to measure.
Most men who see a doctor for a routine checkup receive a standard lipid panel, a basic metabolic panel, and a handshake. They're told their numbers are "normal" and sent on their way — with no understanding of whether "normal" means anything close to optimal, and no longitudinal tracking of the markers that actually predict how they'll age.
This is Medicine 2.0: detect and treat. The problem is that by the time disease is detectable, the biological processes driving it have been accumulating for years or decades. Atherosclerosis begins in your twenties. Insulin resistance is asymptomatic for years before it appears as a diagnosis.
The men who arrive at 70 or 80 with full physical and cognitive capacity are not the ones who got lucky. They are overwhelmingly the ones who measured the right things early, understood what the numbers meant, and intervened — specifically and consistently — long before symptoms appeared.
This is the complete reference for longevity biomarkers, organized into three tiers: what to measure, what the optimal ranges look like, and how to move each number in the right direction.
Not all biomarkers deserve equal attention. The tiered system allows you to start with the highest-impact, most actionable markers and layer in complexity as your sophistication grows.
Tier 1: Essential — High-evidence, high-actionability. Every high-performing man should track these. Widely available through standard labs.
Tier 2: Advanced — Strong evidence, some requiring specialist interpretation or wearable devices. Appropriate for committed trackers and performance optimization.
Tier 3: Cutting Edge — Emerging science, specialized testing, some requiring genetic analysis. For serious longevity-focused individuals who have Tier 1 and 2 dialed in.
Optimal target: <70 mg/dL (high-risk individuals: <55 mg/dL)
Why it matters more than LDL: Every atherogenic lipoprotein particle — LDL, VLDL, IDL, Lp(a) — carries one ApoB molecule. LDL-C measures the cholesterol content within LDL particles but misses the particle count — and it is the particle count that determines how many opportunities there are for arterial wall penetration and plaque formation. Two men can have identical LDL-C of 110 mg/dL. One has ApoB of 65. The other has ApoB of 140. Their cardiovascular risk is categorically different.
Standard lipid panels routinely miss this distinction. Request ApoB specifically — it is not included in a standard lipid panel in most health systems.
Interventions: Dietary reduction of saturated fat (target <10% of calories from saturated fat), elimination of trans fats, aerobic exercise, statins or PCSK9 inhibitors (physician-directed). Omega-3 fatty acids reduce triglycerides and can modestly lower ApoB in hypertriglyceridemic states.
Optimal target: Fasting insulin <5 uIU/mL; HOMA-IR <1.0 (excellent insulin sensitivity)
Why it matters: Fasting insulin is the earliest detectable signal of metabolic dysfunction — often rising years before fasting glucose becomes elevated. HOMA-IR (fasting insulin x fasting glucose / 405) quantifies insulin resistance on a continuous scale. Insulin resistance drives cardiovascular disease, accelerated biological aging, and is the underlying mechanism of type 2 diabetes, non-alcoholic fatty liver disease, and polycystic ovary syndrome.
Most clinical labs flag insulin as "normal" up to 25 uIU/mL — a threshold calibrated to prevent diabetes diagnosis, not optimize metabolic health. High-performing men should target fasting insulin below 5 uIU/mL and HOMA-IR below 1.0.
Interventions: Resistance training (most potent acute intervention), aerobic exercise, time-restricted eating (14–16 hour fasting window), reduction of refined carbohydrates and ultra-processed foods, visceral fat reduction.
Optimal target: <5.3% (excellent); 5.3–5.6% (good); >5.7% (prediabetes territory)
Why it matters: HbA1c reflects average blood glucose over the preceding 90 days by measuring what percentage of hemoglobin has been glycated (sugar-bonded). Unlike fasting glucose, it captures the full glucose load over time, including post-meal spikes. Chronically elevated glucose through glycation damages proteins throughout the body — from arterial walls to the lens of the eye to neuronal tissue.
Interventions: Same as for fasting insulin — exercise is the most potent intervention. Post-meal walks (10 minutes) dramatically reduce post-prandial glucose spikes. Dietary pattern changes (lower glycemic index foods, increased fiber, reduction of liquid calories) compound over the 90-day measurement window.
Optimal target: <0.5 mg/L; <1.0 mg/L acceptable; >3.0 mg/L indicates high cardiovascular risk
Why it matters: hsCRP is the primary circulating marker of systemic inflammation. "Normal" in clinical settings is <3.0 mg/L — calibrated for pathology detection, not optimization. For longevity purposes, the target is below 0.5 mg/L. Chronically elevated CRP predicts cardiovascular events, cancer incidence, cognitive decline, and all-cause mortality with high consistency across the literature.
Note: CRP is a non-specific marker. Elevations require interpretation — acute illness, recent intense exercise, autoimmune flares, and dental disease can all raise CRP transiently. Evaluate in the context of other inflammatory markers.
Interventions: Address root causes: visceral fat reduction, sleep optimization, elimination of ultra-processed foods, dental care, stress management, omega-3 supplementation (2–4g EPA/DHA daily), anti-inflammatory dietary pattern (Mediterranean or similar).
Optimal target: 50–80 ng/mL (125–200 nmol/L)
Why it matters: Vitamin D functions as a hormone, not merely a vitamin. Its receptors are expressed in almost every tissue in the body. Deficiency (<20 ng/mL) is independently associated with increased all-cause mortality, cardiovascular disease, depression, and immune dysfunction. The clinical "sufficient" cutoff of 30 ng/mL is again calibrated to prevent rickets — not optimize longevity. The evidence-based optimal range for high performers is 50–80 ng/mL.
Interventions: Sun exposure (20–30 minutes midday for most latitudes, depending on skin tone); supplementation of 2,000–5,000 IU D3/day with K2 (MK-7 form, 100–200 mcg) to direct calcium appropriately. Retest after 90 days of supplementation to calibrate dose.
Optimal targets: Total T: 600–1,000 ng/dL; Free T: 15–25 pg/mL
Why it matters: Testosterone is not merely the "performance hormone" — it is a critical longevity signal. Low testosterone in men is associated with increased cardiovascular risk, metabolic syndrome, depression, cognitive decline, osteoporosis, and all-cause mortality. The clinical "normal" range (300–1,000 ng/dL) spans an enormous range; a man at 310 is technically "normal" and vastly different physiologically from a man at 850.
Total testosterone alone can be misleading because SHBG (sex hormone-binding globulin) determines bioavailability. Free testosterone — the biologically active fraction — provides the more clinically relevant signal.
Interventions: Sleep (testosterone is primarily secreted during sleep; poor sleep is the most common cause of low-normal T), resistance training, visceral fat reduction, zinc and vitamin D adequacy, stress management (chronically elevated cortisol suppresses testosterone). Testosterone replacement therapy (TRT) under physician supervision for confirmed hypogonadism.
Optimal target: 1.0–2.0 mIU/L (optimal); <0.5 or >4.0 mIU/L requires investigation
Why it matters: The thyroid regulates metabolic rate throughout the body. Subclinical hypothyroidism (TSH >3.0 mIU/L with normal T3/T4) is associated with dyslipidemia, cardiovascular risk, cognitive slowing, and fatigue. Many men operate in a subclinical hypothyroid state that explains energy, body composition, and recovery issues that are otherwise inexplicable.
Interventions: Adequate iodine and selenium (often overlooked), stress management, evaluation by physician with full thyroid panel (TSH, free T3, free T4, anti-TPO antibodies). Levothyroxine if clinically indicated.
Optimal target: >50 mL/kg/min (age 35–44); >47 (age 45–54)
Why it matters: VO2 max is the single strongest predictor of all-cause mortality in the literature. A JAMA study demonstrated that the relative risk of death from low cardiorespiratory fitness exceeds that of smoking, hypertension, or diabetes. Men in the top cardiorespiratory fitness category have a 5x reduction in all-cause mortality risk versus the lowest quartile.
This is not about athletic performance. It is about mitochondrial density, cardiac output capacity, oxygen delivery efficiency, and the underlying physiological reserve that determines how much you can decline before function is compromised.
How to measure: VO2 max testing at a sports medicine or exercise physiology lab (gold standard). Estimated via wearables (Garmin, Polar, Whoop) with reasonable accuracy for trending. Field test: Cooper 12-minute run (calculate from distance covered).
Interventions: Zone 2 training (3–4 hours/week) for aerobic base; VO2 max intervals (4x4 min at >90% max HR, 3 min rest) 1–2x/week.
Optimal target: Personal baseline tracking — absolute values are less important than your individual trend
Why it matters: HRV measures the millisecond variation between consecutive heartbeats — a direct reflection of autonomic nervous system balance between sympathetic (stress) and parasympathetic (recovery) activity. Higher HRV within your personal range indicates better nervous system health, recovery capacity, and resilience to stress. Chronically suppressed HRV predicts cardiovascular events, poor recovery, and psychological burnout.
HRV is highly individual — a 40-year-old with an HRV of 85ms and another with 42ms can both be in excellent health relative to their own baselines. The signal is in the direction and consistency of your personal trend.
How to measure: WHOOP (continuous), Oura Ring (overnight), Garmin/Apple Watch (morning 5-min readings), Polar H10 chest strap (most accurate for clinical reference).
Interventions: Sleep quality (the primary driver), aerobic training, stress management, alcohol elimination (alcohol suppresses HRV acutely), cold exposure (improves parasympathetic tone acutely).
Optimal target: 20–40 nmol/L
Why it matters: SHBG binds testosterone (and other sex hormones), rendering the bound fraction biologically unavailable. Very high SHBG (>60 nmol/L) can mask adequate total testosterone, leaving a man with low free testosterone despite "normal" total T. SHBG rises with age, certain medications, hyperthyroidism, and chronic low caloric intake. SHBG below 20 nmol/L is associated with metabolic syndrome and insulin resistance.
Interventions: SHBG management is largely indirect — address the underlying drivers (insulin resistance raises SHBG, as does liver dysfunction). Zinc adequacy helps modulate SHBG.
Optimal target: Salivary morning cortisol 13–24 nmol/L; serum total cortisol 10–20 mcg/dL
Why it matters: Cortisol follows a diurnal rhythm — high in the morning (cortisol awakening response, CAR), declining through the day. Chronically elevated cortisol drives muscle catabolism, suppresses testosterone, impairs immune function, damages hippocampal neurons, and accelerates biological aging. Flattened or blunted CAR indicates HPA axis dysregulation — a sign of chronic stress exhaustion.
How to measure: Four-point salivary cortisol test (morning, noon, evening, night) provides the most complete picture. Available through functional medicine labs without a prescription.
Interventions: Sleep quality (cortisol pattern is tightly linked to circadian rhythm), stress management, ashwagandha (KSM-66, 300–600mg/day — reduces cortisol by ~15–30% in RCTs), phosphatidylserine (400–800mg/day has evidence for cortisol reduction).
Optimal target: <8 μmol/L; >15 μmol/L indicates elevated risk
Why it matters: Homocysteine is an amino acid produced in the metabolism of methionine. Elevated homocysteine is an independent risk factor for cardiovascular disease, stroke, cognitive decline, and dementia — operating through endothelial damage and thrombosis promotion. It is often elevated due to B vitamin insufficiency (B6, B9/folate, B12) or MTHFR gene polymorphisms that impair methylation.
Interventions: B vitamin optimization — methylated forms are preferred (methylcobalamin, methylfolate/5-MTHF). If homocysteine remains elevated despite B vitamin adequacy, evaluate for MTHFR polymorphism.
Optimal target: Men: 50–150 ng/mL
Why it matters: Ferritin is the primary iron storage protein. Low ferritin (<30 ng/mL) indicates iron depletion and is associated with fatigue, impaired cognitive function, and reduced aerobic performance. Very high ferritin (>300 ng/mL) can indicate iron overload (hereditary hemochromatosis), chronic inflammation, or liver disease — all of which are harmful. Iron overload generates free radicals through Fenton chemistry and is associated with accelerated cardiovascular disease.
Interventions: Low ferritin: dietary iron (heme iron from red meat is most bioavailable), avoid calcium and tannins with iron-rich meals. High ferritin: investigate primary cause; phlebotomy (blood donation) is the most effective iron reduction strategy for iron overload states.
What it is: A genetic test (done once) identifying your ApoE allele combination: E2/E3/E4.
Why it matters: ApoE4 is the strongest known genetic risk factor for late-onset Alzheimer's disease. Carriers of one ApoE4 allele have 3–4x increased risk; two copies carry 8–12x risk. Knowing your ApoE status doesn't change your fate — but it should dramatically change your preventive strategy (earlier and more aggressive cardiovascular and metabolic optimization, sleep priority, aggressive lipid management).
ApoE4 carriers should treat their lifestyle protocol as a non-negotiable investment, not an optional optimization.
Optimal target: <20 U/L (optimal); >40 U/L elevated
Why it matters: GGT is primarily known as a liver enzyme — elevated in alcohol use, liver disease, and bile duct obstruction. But it is increasingly recognized as a sensitive marker of oxidative stress and systemic antioxidant status. GGT rises when the body's glutathione defense system is under strain. Even within "normal" clinical ranges, higher GGT predicts cardiovascular events, diabetes, and all-cause mortality with surprising consistency.
Interventions: Address alcohol consumption (the most common cause), reduce ultra-processed food intake, optimize antioxidant nutrition (cruciferous vegetables, N-acetylcysteine which supports glutathione), liver function optimization.
Optimal target: <5.5 mg/dL
Why it matters: Uric acid is the end product of purine metabolism. Elevated uric acid causes gout — but at subgout levels, elevated uric acid is associated with hypertension, insulin resistance, metabolic syndrome, and cardiovascular disease. It is an emerging metabolic risk marker increasingly recognized as both a consequence and driver of metabolic dysfunction. High fructose intake is a primary driver.
Interventions: Reduce high-fructose inputs (especially fructose-sweetened beverages, not whole fruit), reduce alcohol (especially beer), adequate hydration, tart cherry extract (modest uric acid reduction evidence).
What they are: Commercial tests using DNA methylation analysis from a blood or saliva sample to generate biological age estimates using multiple epigenetic clocks (DunedinPACE, GrimAge, PhenoAge, and others).
Why they matter: This is the most direct measure of biological aging currently available to consumers. Unlike proxy biomarkers, epigenetic clocks measure the aging process at the level of the genome. They are the closest thing we have to a speedometer for biological aging — and they respond to interventions in a measurable timeframe.
How to get tested: TruDiagnostic and Elysium Index are the current market leaders in consumer epigenetic age testing. Retest annually to measure trajectory. The rate of change (DunedinPACE) is more informative than any single-point measurement.
Request specifically:
Most are covered by insurance with a preventive care code. Bring this list and a clear rationale.
| Biomarker | Retest Frequency |
|---|---|
| ApoB, LDL, lipid panel | Every 6 months if optimizing; annually when stable |
| Fasting insulin, HOMA-IR, HbA1c | Every 3–6 months if metabolically optimizing |
| hsCRP | Every 3–6 months; quarterly if elevated |
| Testosterone (total + free), SHBG | Every 6 months |
| Vitamin D | Every 6 months (seasonal variation matters) |
| TSH | Annually unless symptomatic |
| Homocysteine | Annually |
| Ferritin | Annually |
| GGT | Annually with liver panel |
| Uric acid | Annually or if dietary changes |
| VO2 max | Every 3–6 months when actively training |
| HRV | Daily (wearable tracking) |
| Epigenetic age | Annually |
Start tracking what matters.
Deep-dive reference pages for every biomarker, with optimal ranges, intervention protocols, and test ordering guides.
New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.